Intellectus Partners LLC Buys New Shares in Lam Research Corporation $LRCX

Intellectus Partners LLC bought a new stake in shares of Lam Research Corporation (NASDAQ:LRCX) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 15,677 shares of the semiconductor company’s stock, valued at approximately $1,530,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Burney Co. grew its holdings in shares of Lam Research by 10.4% during the 2nd quarter. Burney Co. now owns 324,314 shares of the semiconductor company’s stock valued at $31,569,000 after purchasing an additional 30,436 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co grew its holdings in Lam Research by 0.7% in the 2nd quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 88,743 shares of the semiconductor company’s stock worth $8,638,000 after acquiring an additional 607 shares during the last quarter. Telos Capital Management Inc. grew its holdings in Lam Research by 4.6% in the 2nd quarter. Telos Capital Management Inc. now owns 5,662 shares of the semiconductor company’s stock worth $551,000 after acquiring an additional 250 shares during the last quarter. Sigma Planning Corp grew its holdings in Lam Research by 1.5% in the 2nd quarter. Sigma Planning Corp now owns 18,208 shares of the semiconductor company’s stock worth $1,772,000 after acquiring an additional 272 shares during the last quarter. Finally, TIAA Trust National Association grew its holdings in Lam Research by 2.0% in the 2nd quarter. TIAA Trust National Association now owns 34,414 shares of the semiconductor company’s stock worth $3,350,000 after acquiring an additional 691 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.

Insider Transactions at Lam Research

In related news, insider Ava Harter sold 9,010 shares of Lam Research stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the completion of the transaction, the insider directly owned 56,786 shares of the company’s stock, valued at $8,942,091.42. This trade represents a 13.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.31% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on LRCX shares. KeyCorp raised their price target on shares of Lam Research from $105.00 to $115.00 and gave the stock an “overweight” rating in a report on Tuesday, July 15th. B. Riley raised their price target on shares of Lam Research from $160.00 to $175.00 and gave the stock a “buy” rating in a report on Monday, October 20th. BNP Paribas Exane raised their price target on shares of Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a report on Thursday, October 23rd. Citigroup raised their price target on shares of Lam Research from $120.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Finally, Mizuho raised their price target on shares of Lam Research from $162.00 to $170.00 and gave the stock an “outperform” rating in a report on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $148.54.

Lam Research Trading Down 2.2%

Shares of LRCX opened at $157.46 on Monday. The firm’s 50-day moving average price is $129.13 and its 200-day moving average price is $103.49. The firm has a market capitalization of $197.77 billion, a price-to-earnings ratio of 34.68, a PEG ratio of 1.68 and a beta of 1.84. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $165.22.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s revenue for the quarter was up 27.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Sell-side analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th were given a dividend of $0.26 per share. This is an increase from Lam Research’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Wednesday, September 24th. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. Lam Research’s dividend payout ratio is 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.